Paper42016206
Hydroxychloroquine Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice: Role of Endothelial Nitric Oxide Synthase and Hypoxia-Inducible Factor 1-Alpha.
Poulakida E and 14 others. Cardiol Res, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Hydroxychloroquine Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice: Role of Endothelial Nitric Oxide Synthase and Hypoxia-Inducible Factor 1-Alpha. Papers, record 42016206. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42016206
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Hydroxychloroquine Attenuates Atherosclerosis in Apolipoprotein E Knockout Mice: Role of Endothelial Nitric Oxide Synthase and Hypoxia-Inducible Factor 1-Alpha.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21199675 | Interactions between nitric oxide and hypoxia-inducible factor signaling pathways in inflammatory disease. | Nitric Oxide | 2011 | https://conductscience.org/library/papers/21199675 | PubMed |
| 2 | 17658499 | Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. | Cardiovasc Res | 2008 | https://conductscience.org/library/papers/17658499 | PubMed |
| 3 | 11555803 | Treatment of hydroxychloroquine overdose. | Am J Emerg Med | 2001 | https://conductscience.org/library/papers/11555803 | PubMed |
| 4 | 26444671 | Early treatment with hydroxychloroquine prevents the development of endothelial dysfunction in a murine model of systemic lupus erythematosus. | Arthritis Res Ther | 2015 | https://conductscience.org/library/papers/26444671 | PubMed |
| 5 | 38929125 | Artesunate Exerts Organ- and Tissue-Protective Effects by Regulating Oxidative Stress, Inflammation, Autophagy, Apoptosis, and Fibrosis: A Review of Evidence and Mechanisms. | Antioxidants (Basel) | 2024 | https://conductscience.org/library/papers/38929125 | PubMed |
| 6 | 27444197 | Hypoxia-Inducible Factor-1α Expression in Macrophages Promotes Development of Atherosclerosis. | Arterioscler Thromb Vasc Biol | 2016 | https://conductscience.org/library/papers/27444197 | PubMed |
| 7 | 36817159 | Anti-malarial artesunate ameliorates atherosclerosis by modulating arterial inflammatory responses via inhibiting the NF-κB-NLRP3 inflammasome pathway. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36817159 | PubMed |
| 8 | 24834516 | Policy: NIH to balance sex in cell and animal studies. | Nature | 2014 | https://conductscience.org/library/papers/24834516 | PubMed |
| 9 | 11397713 | Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. | Arterioscler Thromb Vasc Biol | 2001 | https://conductscience.org/library/papers/11397713 | PubMed |
| 10 | 36197529 | Hydroxychloroquine and Cardiovascular Events in Patients with Rheumatoid Arthritis. | Cardiovasc Drugs Ther | 2024 | https://conductscience.org/library/papers/36197529 | PubMed |
| 11 | 3426656 | Quantitative assessment of atherosclerotic lesions in mice. | Atherosclerosis | 1987 | https://conductscience.org/library/papers/3426656 | PubMed |
| 12 | 11238274 | Endothelial regulation of vasomotion in apoE-deficient mice: implications for interactions between peroxynitrite and tetrahydrobiopterin. | Circulation | 2001 | https://conductscience.org/library/papers/11238274 | PubMed |
| 13 | 30832409 | Hypoxia-Inducible Factors and the Regulation of Lipid Metabolism. | Cells | 2019 | https://conductscience.org/library/papers/30832409 | PubMed |
| 14 | 21372297 | Detection of hypoxia by [18F]EF5 in atherosclerotic plaques in mice. | Arterioscler Thromb Vasc Biol | 2011 | https://conductscience.org/library/papers/21372297 | PubMed |
| 15 | 17412315 | Nitric oxide and superoxide: interference with hypoxic signaling. | Cardiovasc Res | 2007 | https://conductscience.org/library/papers/17412315 | PubMed |
| 16 | 19345314 | Spontaneous myocardial infarction and nitric oxide synthase. | Trends Cardiovasc Med | 2008 | https://conductscience.org/library/papers/19345314 | PubMed |
| 17 | 39862086 | HIF-1α and VEGF Immunophenotypes as Potential Biomarkers in the Prognosis and Evaluation of Treatment Efficacy of Atherosclerosis: A Systematic Review of the Literature. | Front Biosci (Landmark Ed) | 2025 | https://conductscience.org/library/papers/39862086 | PubMed |
| 18 | 26414017 | Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease. | PLoS One | 2015 | https://conductscience.org/library/papers/26414017 | PubMed |
| 19 | 21921268 | Hypoxia is present in murine atherosclerotic plaques and has multiple adverse effects on macrophage lipid metabolism. | Circ Res | 2011 | https://conductscience.org/library/papers/21921268 | PubMed |
| 20 | 23375596 | Hypoxia in murine atherosclerotic plaques and its adverse effects on macrophages. | Trends Cardiovasc Med | 2013 | https://conductscience.org/library/papers/23375596 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42016206
GET https://conductscience.org/api/papers/v1/42016206/references?page=2